Next |
home / stock / umrx / umrx message board
Subject | By | Source | When |
---|---|---|---|
$UMRX / #UNUM Therapeutics Potential 25% Upside | TFMG | investorshub | 08/25/2020 2:09:49 PM |
Do not* | byrdiesoccer | investorshub | 07/28/2020 3:03:52 AM |
Do waste your time with that poster. Venrock | byrdiesoccer | investorshub | 07/28/2020 2:50:58 AM |
Tell that to all the new major fund | cjstocksup | investorshub | 07/27/2020 6:14:22 PM |
Now you may ride it all the way | surf1944 | investorshub | 07/27/2020 4:34:28 PM |
ROTFLMAO we already rode it up to almost | cjstocksup | investorshub | 07/27/2020 4:29:39 PM |
https://www.stockscores.com/charts/charts/?ticker=$UMRX Open gap on the cha | surf1944 | investorshub | 07/27/2020 4:03:37 PM |
I agree and based on the chart and | cjstocksup | investorshub | 07/27/2020 1:48:54 PM |
This one will run very soon. Venrock doesnt play.... | byrdiesoccer | investorshub | 07/27/2020 11:03:12 AM |
It was news a few days ago. This | cjstocksup | investorshub | 07/23/2020 1:30:26 PM |
Why has this not been mentioned?: | aljafy | investorshub | 07/23/2020 12:43:48 PM |
I agree. Read all the 13g's lately. Big | cjstocksup | investorshub | 07/22/2020 1:48:46 PM |
Follow Venrock money when you can. They loaded | byrdiesoccer | investorshub | 07/22/2020 11:29:02 AM |
$UMRX VENROCK takes 5% stake another big 13 | cjstocksup | investorshub | 07/21/2020 5:11:41 AM |
$UMRX another 13g afterhours today. Could move up | cjstocksup | investorshub | 07/20/2020 9:04:07 PM |
UMRX 104 million dollars on the recent buyout, | cjstocksup | investorshub | 07/17/2020 10:37:58 AM |
$UMRX moved afterhours I see because of more | cjstocksup | investorshub | 07/17/2020 1:44:25 AM |
Right! Amazing play here. Raised over $100M and | PickleNick | investorshub | 07/10/2020 9:47:24 PM |
$UMRX! I agree! $5.00 Monday for $UMRX? Shorts | cjstocksup | investorshub | 07/10/2020 9:37:00 PM |
* * $UMRX Video Chart 07-10-2020 * * | ClayTrader | investorshub | 07/10/2020 8:39:38 PM |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced Andrew Robbins, Chief Executive Officer and President, wil...
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress Cogent Biosciences is focused on the design of rational precision therapies to improve the lives of patients Company on track to advance CGT9486 into ...
SOTIO will establish a T cell therapy R&D Center of Excellence in Cambridge, Massachusetts Unum’s former chief technology officer Geoff Hodge to join SOTIO to lead BOXR development team and all research and development of the next generation T cell therapies Lead progra...